DE69209228D1 - Acetazolamide Formulierung mit verzögerter Wirkstoffabgabe - Google Patents

Acetazolamide Formulierung mit verzögerter Wirkstoffabgabe

Info

Publication number
DE69209228D1
DE69209228D1 DE69209228T DE69209228T DE69209228D1 DE 69209228 D1 DE69209228 D1 DE 69209228D1 DE 69209228 T DE69209228 T DE 69209228T DE 69209228 T DE69209228 T DE 69209228T DE 69209228 D1 DE69209228 D1 DE 69209228D1
Authority
DE
Germany
Prior art keywords
acetazolamide
formulation
drug delivery
delayed drug
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69209228T
Other languages
English (en)
Other versions
DE69209228T2 (de
Inventor
Nicholas Ian Payne
David Parker
Angela Catherine Potts
Laurence Charles Staines
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE69209228D1 publication Critical patent/DE69209228D1/de
Application granted granted Critical
Publication of DE69209228T2 publication Critical patent/DE69209228T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69209228T 1991-06-11 1992-05-18 Acetazolamide Formulierung mit verzögerter Wirkstoffabgabe Expired - Lifetime DE69209228T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9112495A GB2256587A (en) 1991-06-11 1991-06-11 Acetazolamide in sustained release form

Publications (2)

Publication Number Publication Date
DE69209228D1 true DE69209228D1 (de) 1996-04-25
DE69209228T2 DE69209228T2 (de) 1996-11-21

Family

ID=10696429

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69209228T Expired - Lifetime DE69209228T2 (de) 1991-06-11 1992-05-18 Acetazolamide Formulierung mit verzögerter Wirkstoffabgabe

Country Status (11)

Country Link
EP (1) EP0540813B1 (de)
AT (1) ATE135568T1 (de)
CA (1) CA2070877C (de)
DE (1) DE69209228T2 (de)
DK (1) DK0540813T3 (de)
ES (1) ES2086576T3 (de)
FI (1) FI101855B1 (de)
GB (1) GB2256587A (de)
GR (1) GR3019751T3 (de)
NO (1) NO922282L (de)
ZA (1) ZA924242B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
AR036797A1 (es) 2001-10-15 2004-10-06 Ferring Bv Un metodo para preparar una composicion farmaceutica que comprende acido 5-aminosalicilico para utilizar en el tratamiento de colitis ulcerosa y enfermedades de crohn
JP2007523664A (ja) 2003-04-23 2007-08-23 フェリング ベスローテン フェンノートシャップ 医薬組成物用サシェ
EP1547601A1 (de) 2003-12-23 2005-06-29 Ferring B.V. Beschichtungsverfahren
KR20100049500A (ko) 2007-03-15 2010-05-12 쉐링 코포레이션 글루칸 신타제 억제제로서 유용한 피리다지논 유도체
CN102949377B (zh) * 2012-11-28 2015-05-27 河南中帅医药科技股份有限公司 乙酰唑胺缓释胶囊及其制备方法
CN106822015A (zh) * 2017-03-27 2017-06-13 华益药业科技(安徽)有限公司 乙酰唑胺缓释片及其制备方法
CN113855648B (zh) * 2021-12-03 2022-02-25 北京联嘉医药科技开发有限公司 一种乙酰唑胺缓释胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3671633A (en) * 1971-05-10 1972-06-20 American Cyanamid Co Process for tabletting acetazolamide
US4305927A (en) * 1979-02-05 1981-12-15 Alza Corporation Method for the management of intraocular pressure
GB2135879B (en) * 1983-03-07 1986-05-21 Ciba Geigy Ag Pharmaceutical preparations with uniform elution properties
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form

Also Published As

Publication number Publication date
FI922698A (fi) 1992-12-12
ES2086576T3 (es) 1996-07-01
GB2256587A (en) 1992-12-16
GR3019751T3 (en) 1996-07-31
NO922282L (no) 1992-12-14
EP0540813A1 (de) 1993-05-12
ZA924242B (en) 1993-03-31
GB9112495D0 (en) 1991-07-31
FI101855B (fi) 1998-09-15
DK0540813T3 (da) 1996-07-22
DE69209228T2 (de) 1996-11-21
CA2070877C (en) 2003-02-11
ATE135568T1 (de) 1996-04-15
FI101855B1 (fi) 1998-09-15
EP0540813B1 (de) 1996-03-20
FI922698A0 (fi) 1992-06-10
NO922282D0 (no) 1992-06-10
CA2070877A1 (en) 1992-12-12

Similar Documents

Publication Publication Date Title
DK288987D0 (da) Et afgivelsessystem til doseringsformerne forhalet afgivelse, samt dettes fremstilling
ATE75936T1 (de) Zusammensetzungen mit verzoegerten wirkstoffabgaben.
SE9102072L (sv) Oral, fast, farmaceutisk doseringsform med styrd frisaettning
DE68911027D1 (de) Pheromondispenser mit verlängerter Freisetzung.
DE69229949D1 (de) Diltiazem enthaltende arzneimittel mit verzögerter wirkstoffabgabe
ATE64091T1 (de) Tablette mit verzoegerter freisetzung.
DE69431247D1 (de) Oxybutyninformulierungen mit gesteuerter freisetzung
DE60005819D1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
DE3855852D1 (de) Kugelförmige Granula mit Kern sowie deren Herstellung
DE69022876T3 (de) Arzneimittelformulierungen mit verzögerter Wirkstoffabgabe.
DE59003337D1 (de) Pressling mit retardierter Wirkstofffreisetzung.
AU4694189A (en) 2-(4,6-dimethoxy-2-pyrimidinyloxy)benzaldoximes, preparation processes thereof, herbicides containing G the same, and herbicidal compositions containing the same along with other active ingredient
MX9202053A (es) Composiciones herbicidas con seguridad incrementada para el cultivo.
ATE469644T1 (de) Pharmazeutische zubereitung enthaltend n-ä2-(1,6, 7,8-tetrahydro-2h-indenoä5,4 büfuran-8- yl)ethylüpropionamid ummantelt mit einer copolyvidon-enthaltenden, polyäthylenglykolfreien umhüllung
DE69209228T2 (de) Acetazolamide Formulierung mit verzögerter Wirkstoffabgabe
ATE144701T1 (de) Verwendung einer kombination aus gelbindender polysacchariden und fein verteilten arzneimittelträgern in ophtalmischen topischen zusammensetzungen
DE3881208D1 (de) Schaedlinge abweisende mikrokapseln mit verzoegerter abgabe.
TR28830A (tr) Insektisid özellikte N'-sübstitüe edilmis N,N`- diacilhidrazinler.
DE69831940D1 (de) Tablette mit verlängerter Wirkstoffabgabe im Magen
FR2661070B1 (fr) Compositions insecticides a base de chrysanthemate de 2,4-dioxo-1-(2-propynyl) imidazolidine-3-ylmethyle.
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
ES2127259T3 (es) Sistema de liberacion prolongada de piribedil.
IT8922398A0 (it) Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.
IT1295210B1 (it) Concime od integratore per le piante, a base di propoli e procedimento per la fabbricazione e per l'uso di tale concime.
SV1988000015A (es) Procedimiento para preparar pirazolinas, ref. p-sal-44,240.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH HOLDINGS CORP., MADISON, N.J., US